These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27871438)

  • 1. Chewing-induced blepharospasm in Parkinson's disease.
    Spitz M; Sasse E; Vasconcellos LF; de Souza E Silva D; Pereira JS
    J Neurol Sci; 2016 Dec; 371():15-16. PubMed ID: 27871438
    [No Abstract]   [Full Text] [Related]  

  • 2. Peak-dose dyskinesia; an acceptable price for mobility in late-stage Parkinson's disease?
    Wenzelburger R
    Clin Neurophysiol; 2005 Sep; 116(9):1997-8. PubMed ID: 16055380
    [No Abstract]   [Full Text] [Related]  

  • 3. Lees' syndrome: a case series.
    Becker N; Munhoz RP; Teive HA
    Arq Neuropsiquiatr; 2011 Oct; 69(5):756-9. PubMed ID: 22042176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexpected improvement in levodopa-induced dyskinesia and on-off phenomena after introduction of memantine for treatment of Parkinson's disease dementia.
    Vidal EI; Fukushima FB; Valle AP; Villas Boas PJ
    J Am Geriatr Soc; 2013 Jan; 61(1):170-2. PubMed ID: 23311565
    [No Abstract]   [Full Text] [Related]  

  • 5. Serotonergic involvement in levodopa-induced dyskinesias in Parkinson's disease.
    Cheshire PA; Williams DR
    J Clin Neurosci; 2012 Mar; 19(3):343-8. PubMed ID: 22249009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders.
    Voon V; Fernagut PO; Wickens J; Baunez C; Rodriguez M; Pavon N; Juncos JL; Obeso JA; Bezard E
    Lancet Neurol; 2009 Dec; 8(12):1140-9. PubMed ID: 19909912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of motor complications in treatment of Parkinson's disease.
    Kumar A; Huang Z; de la Fuente-Fernández R
    Adv Neurol; 2003; 91():193-201. PubMed ID: 12442678
    [No Abstract]   [Full Text] [Related]  

  • 8. [Parkinson's disease].
    Yokochi M
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):5-14. PubMed ID: 10434578
    [No Abstract]   [Full Text] [Related]  

  • 9. Medications for Parkinson's disease.
    Whitney CM
    Neurologist; 2007 Nov; 13(6):387-8. PubMed ID: 18090719
    [No Abstract]   [Full Text] [Related]  

  • 10. NMDA antagonist memantine improves levodopa-induced dyskinesias and "on-off" phenomena in Parkinson's disease.
    Varanese S; Howard J; Di Rocco A
    Mov Disord; 2010 Mar; 25(4):508-10. PubMed ID: 20014061
    [No Abstract]   [Full Text] [Related]  

  • 11. [Continuous dopaminergic stimulation, pulsatile dopaminergic stimulation].
    Destée A; Bordet R
    Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S69-82. PubMed ID: 12690666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacology of levodopa-induced dyskinesia in parkinsonian patients.
    Rascol O; Brefel-Courbon C; Descombes S; Montastruc JL
    Adv Neurol; 1999; 80():485-90. PubMed ID: 10410760
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacotherapy for Parkinson's disease: current options, promising future therapies.
    Moser SS; Besler-Panos W
    JAAPA; 2006 Aug; 19(8):38-44. PubMed ID: 16918085
    [No Abstract]   [Full Text] [Related]  

  • 14. Drugs for Parkinson's disease.
    Treat Guidel Med Lett; 2011 Jan; 9(101):1-6; quiz 2 p following 6. PubMed ID: 21304446
    [No Abstract]   [Full Text] [Related]  

  • 15. Impulse control disorders and subthalamic nucleus stimulation in Parkinson's disease: are we jumping the gun?
    Moro E
    Eur J Neurol; 2009 Apr; 16(4):440-1. PubMed ID: 19348620
    [No Abstract]   [Full Text] [Related]  

  • 16. Continuous dopaminergic therapy in Parkinson disease: time to stride back?
    Stoessl AJ
    Ann Neurol; 2010 Jul; 68(1):3-5. PubMed ID: 20583222
    [No Abstract]   [Full Text] [Related]  

  • 17. Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model.
    de la Fuente-Fernández R; Schulzer M; Mak E; Calne DB; Stoessl AJ
    Brain; 2004 Apr; 127(Pt 4):888-99. PubMed ID: 14960500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involuntary movements in the elderly. Parkinson's disease and other causes.
    Miller JQ
    Postgrad Med; 1986 Mar; 79(4):323-30. PubMed ID: 3952049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-Hz repetitive transcranial magnetic stimulation and diphasic dyskinesia in Parkinson's disease.
    Filipović SR; Bhatia KP; Rothwell JC
    Mov Disord; 2013 Feb; 28(2):245-6. PubMed ID: 23144006
    [No Abstract]   [Full Text] [Related]  

  • 20. Dyskinesia in Parkinson disease: back for the future?
    Vingerhoets FJ
    Neurology; 2009 Apr; 72(14):1202-3. PubMed ID: 19349599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.